Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial.
CONCLUSION: We developed a convenient nomogram to estimate the benefit of IC for individual patients with LANPC. This tool can serve as a catalyst of individual treatment discussions and facilitator of informed decision-making.
PMID: 29258695 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Zhang Y, Li WF, Liu X, Chen L, Sun R, Sun Y, Liu Q, Ma J Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | Nasopharyngeal Cancer | Radiology | Study